7PG0 image
Deposition Date 2021-08-12
Release Date 2022-02-02
Last Version Date 2024-10-23
Entry Detail
PDB ID:
7PG0
Title:
Low resolution Cryo-EM structure of full-length insulin receptor bound to 3 insulin with visible ddm micelle, conf 1
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
7.60 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Isoform Short of Insulin receptor
Gene (Uniprot):INSR
Chain IDs:A, B
Chain Length:1382
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Insulin
Gene (Uniprot):INS
Chain IDs:C, E, G (auth: I)
Chain Length:21
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Insulin
Gene (Uniprot):INS
Chain IDs:D, F, H (auth: J)
Chain Length:30
Number of Molecules:3
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Structural Investigations of Full-Length Insulin Receptor Dynamics and Signalling.
J.Mol.Biol. 434 167458 167458 (2022)
PMID: 35074483 DOI: 10.1016/j.jmb.2022.167458

Abstact

Insulin regulates glucose homeostasis via binding and activation of the insulin receptor dimer at two distinct pairs of binding sites 1 and 2. Here, we present cryo-EM studies of full-length human insulin receptor (hIR) in an active state obtained at non-saturating, physiologically relevant insulin conditions. Insulin binds asymmetrically to the receptor under these conditions, occupying up to three of the four possible binding sites. Deletion analysis of the receptor together with site specific peptides and insulin analogs used in binding studies show that both sites 1 and 2 are required for high insulin affinity. We identify a homotypic interaction of the fibronectin type III domain (FnIII-3) of IR resulting in tight interaction of membrane proximal domains of the active, asymmetric receptor dimer. Our results show how insulin binding at two distinct types of sites disrupts the autoinhibited apo-IR dimer and stabilizes the active dimer. We propose an insulin binding and activation mechanism, which is sequential, exhibits negative cooperativity, and is based on asymmetry at physiological insulin concentrations with one to three insulin molecules activating IR.

Legend

Protein

Chemical

Disease

Primary Citation of related structures